Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis
Eline M. E. Coerver(Amsterdam Neuroscience), Eva Strijbis(Amsterdam University Medical Centers), Esther Zeinstra(Isala), Willem H. Bouvy(Diakonessenhuis hospital), Zoé L. E. van Kempen(Amsterdam Neuroscience), Birgit I. Lissenberg‐Witte(OLVG), Leo R. Canta(Radboud University Nijmegen), Harry Lövenich(St.Jans Gasthuis Weert), Oliver H. H. Gerlach(Maastricht University), Caspar E.P. van Munster(Amphia Ziekenhuis), Joost Smolders(Royal Netherlands Academy of Arts and Sciences), Bastiaan Moraal(Amsterdam UMC Location Vrije Universiteit Amsterdam), Bob W. van Oosten(Amsterdam Neuroscience), Elske Hoitsma(Alrijne Ziekenhuis), Frederik Barkhof(Netherlands Institute for Neuroscience), Anke Vennegoor(Flevoziekenhuis), Brigit A. de Jong(Amsterdam Neuroscience), Gijs Kooij(Amsterdam Neuroscience), Nynke F. Kalkers(OLVG), Menno M. Schoonheim(Amsterdam Neuroscience), Charlotte E. Teunissen(Amsterdam Neuroscience), Joep Killestein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Mar Barrantes-Cepas(Amsterdam Neuroscience), Wing Hee Fung(Amsterdam Neuroscience), E.L.J. Hoogervorst(St. Antonius Ziekenhuis), Jop Mostert(Rijnstate Hospital), Janet de Beukelaar(Albert Schweitzer Ziekenhuis), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 29
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k